日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Developing and validating a predictive model for all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease

建立并验证代谢功能障碍相关脂肪肝患者全因死亡率预测模型

期刊:Diabetology & Metabolic Syndrome
影响因子:3.9
doi:10.1186/s13098-025-01724-6
Zhang, Fan; Liu, Longgen; Li, Wenjian
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States

肌少症与代谢功能障碍相关脂肪肝患者肝纤维化进展的相关性：来自中国和美国两个队列的研究

期刊:Nutrition Journal
影响因子:3.8
doi:10.1186/s12937-025-01081-0
Zhang, Fan; Liu, Longgen; Li, Wenjian
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Validation of the diagnostic accuracy of the acFibroMASH index for at-risk MASH in patients with metabolic dysfunction-associated steatotic liver disease

验证acFibroMASH指数对代谢功能障碍相关脂肪肝患者发生MASH风险的诊断准确性

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-025-03781-7
Wu, Yunfei; Han, Yan; Zheng, Liming; Liu, Longgen; Li, Wenjian; Zhang, Fan
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Erjingpill bionic cerebrospinal fluid alleviates LPS-induced inflammatory response in BV2 cells by inhibiting glycolysis via mTOR

二精丸仿生脑脊液通过mTOR抑制糖酵解减轻LPS诱导的BV2细胞炎症反应

期刊:Journal of Ethnopharmacology
影响因子:4.8
doi:10.1016/j.jep.2024.118412
Shuaikang Wang, Li Wu, Yongyan Xie, Shuchao Ge, Yi Wu, Liping Chen, Longgen Yi, Jie Yang, Feipeng Duan, Liping Huang
信号转导
其它细胞
mTOR
发表日期：2024
文献求助 收藏

Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS

采用液相色谱-串联质谱法（LC-MS/MS）鉴定乙型肝炎病毒相关肝细胞癌患者血清胆汁酸谱的改变

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-024-05686-6
Dai, Sijia; Zhu, Jingfei; Chen, Xuqiong; Zheng, Liming; Li, Xiaoping; Liu, Longgen
肿瘤
肿瘤免疫
多发性硬化症
微生物学
细胞生物学
肝炎
发表日期：2024
文献求助 收藏

Non-invasive prediction nomogram for predicting significant fibrosis in patients with metabolic-associated fatty liver disease: a cross-sectional study

用于预测代谢相关脂肪肝患者显著纤维化的无创预测列线图：一项横断面研究

期刊:
影响因子:
doi:10.1080/07853890.2024.2337739
Zhang, Fan; Han, Yan; Mao, Yonghua; Zheng, Guojun; Liu, Longgen; Li, Wenjian
脂肪肝
代谢
发表日期：2024
文献求助 收藏

Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study

非侵入性标志物与非酒精性脂肪性肝病患者显著纤维化的相关性：一项横断面研究

期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S417754
Zhang, Fan; Han, Yan; Zheng, Liming; Liu, Jianhong; Wu, Yunfei; Bao, Zuowei; Liu, Longgen; Li, Wenjian
脂肪肝
发表日期：2023
文献求助 收藏

Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

阿利西尤单抗对预防冠心病患者冠状动脉支架植入术围手术期缺血事件的影响（APPEASE试验）：一项多中心、开放标签、随机对照试验的研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-072541
Huang, Zhuoshan; Zhuang, Xiaodong; Zhang, Shaozhao; Huang, Yiquan; Yuan, Lianxiong; Lin, Aiwen; Tang, Leile; Xiong, Zhenyu; Christopher, Odong; Chen, Yang; Wu, Bingyuan; Ling, Yesheng; Li, Suhua; Jie, Qiang; Xiong, Longgen; Qian, Xiaoxian; Liao, Xinxue; Liu, Jinlai
APP
心血管
冠心病
发表日期：2023
文献求助 收藏

P(v) intermediate-mediated E1cB elimination for the synthesis of glycals

P(v)中间体介导的E1cB消除反应用于糖苷的合成

期刊:Chemical Science
影响因子:7.4
doi:10.1039/d2sc01423h
Liu, Fen; Huang, Haiyang; Sun, Longgen; Yan, Zeen; Tan, Xiao; Li, Jing; Luo, Xinyue; Ding, Haixin; Xiao, Qiang
发表日期：2022
文献求助 收藏

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores

对于伴有高肝细胞癌风险评分的乙肝病毒相关代偿性肝硬化患者，替诺福韦在降低肝细胞癌发生率方面优于恩替卡韦。

期刊:Therapeutic Advances in Chronic Disease
影响因子:2.8
doi:10.1177/20406223221102791
Huang, Yan; Chen, Lichang; Huang, Rui; Zhu, Chuanwu; Shang, Jia; Qian, Yunsong; Lian, Jianqi; Liu, Longgen; Jiang, Jianning; Liu, Chenghai; Gui, Honglian; Xie, Qing
肿瘤
肿瘤免疫
微生物学
肝硬化
细胞生物学
发表日期：2022
文献求助 收藏